HBIO
HARVARD BIOSCIENCE INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$8.80
+4.51%Oct 6, 2026, 20:05 UTC
Harvard Bioscience announced the creation of a HARVARD BIOSCIENCE INC to guide its research, development and new product roadmaps.
Source:Aug 11, 2026, 17:47 UTC
Harvard Bioscience, Inc. held its Q2 2026 earnings call on August 11, 2026, discussing financial results for the quarter.
Jun 2, 2026, 00:00 UTC
Harvard Bioscience Inc elected John Duke and Katherine A. Eade as Class II Directors effective June 2, 2026.